US Stock MarketDetailed Quotes

BAER Bridger Aerospace

Watchlist
  • 1.370
  • -0.160-10.46%
Close Mar 21 16:00 ET
  • 1.500
  • +0.130+9.45%
Post 19:57 ET
74.28MMarket Cap-1.69P/E (TTM)

Bridger Aerospace Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
134.90%9.36M
-37.42%9.19M
90.10%22.72M
83.35%-2.8M
46.08%-19.76M
-170.30%-26.81M
849.41%14.68M
477.35%11.95M
-542.93%-16.79M
-394.15%-36.65M
Net income from continuing operations
79.88%-15.57M
58.75%-12.85M
56.37%27.35M
47.53%-9.98M
55.05%-20.09M
-83.64%-77.36M
-82.76%-31.14M
409.48%17.49M
-316.89%-19.02M
-200.44%-44.69M
Operating gains losses
-28,127.78%-5.05M
76.78%-398K
-175.43%-1.85M
-231.56%-1.88M
57.66%-912K
-99.51%18K
-233.59%-1.71M
54.10%2.45M
--1.43M
-375.63%-2.15M
Depreciation and amortization
57.37%17.45M
214.85%2.69M
118.58%11.47M
-38.24%2M
-26.33%1.29M
21.98%11.09M
61.60%855K
17.48%5.25M
14.39%3.24M
38.21%1.75M
Deferred tax
-233.92%-1.14M
-90.64%-652K
--0
----
----
---342K
---342K
--0
----
----
Other non cash items
-51.54%550K
-251.83%-621K
115.70%522K
80.41%442K
-13.39%207K
-72.90%1.14M
30.85%409K
21.53%242K
-68.33%245K
-91.77%239K
Change In working capital
73.86%-3.05M
-47.78%18.57M
9.71%-18.13M
127.08%2.64M
64.75%-6.13M
-202.93%-11.68M
174.60%35.57M
-1,227.48%-20.08M
-275.59%-9.76M
-795.53%-17.4M
-Change in receivables
-96.59%-2.13M
-24.57%18.32M
-7.17%-14.56M
55.63%-5.08M
-140.53%-813K
-18,183.33%-1.09M
122.99%24.29M
-116.54%-13.59M
-146.38%-11.45M
-1,065.94%-338K
-Change in inventory
-108.17%-104K
----
----
----
----
595.63%1.27M
----
----
----
----
-Change in prepaid assets
196.01%2.29M
-41.38%983K
108.07%58K
191.04%1.62M
90.27%-379K
-540.05%-2.38M
2,606.58%1.68M
13.15%-719K
1,756.92%558K
-800.37%-3.9M
-Change in payables and accrued expense
67.30%-3.1M
-107.01%-673K
37.57%-3.57M
438.31%6.1M
65.82%-4.95M
-182.27%-9.48M
351.33%9.6M
-202.67%-5.73M
-44.75%1.13M
-917.97%-14.49M
-Change in other current assets
----
----
-7.55%-57K
---1K
-99.10%12K
----
----
---53K
--0
856.03%1.33M
Cash from discontinued investing activities
Operating cash flow
134.90%9.36M
-37.42%9.19M
90.10%22.72M
83.35%-2.8M
46.08%-19.76M
-170.30%-26.81M
849.41%14.68M
477.35%11.95M
-542.93%-16.79M
-394.15%-36.65M
Investing cash flow
Cash flow from continuing investing activities
-92.43%2.06M
122.73%1.98M
-118.77%-1.37M
-89.35%1.66M
-101.65%-214K
130.24%27.16M
56.60%-8.69M
111.99%7.29M
334.81%15.61M
650.95%12.96M
Capital expenditure reported
-252.44%-1.16M
44.21%-183K
---217K
---444K
---312K
---328K
---328K
--0
--0
--0
Net PPE purchase and sale
82.76%-3.44M
68.67%-841K
62.61%-1.15M
76.36%-486K
92.09%-957K
43.25%-19.92M
30.00%-2.68M
86.18%-3.08M
69.06%-2.06M
-414.56%-12.1M
Net business purchase and sale
--2.59M
--0
--0
----
----
--0
--0
--0
----
----
Net investment purchase and sale
-97.91%1.06M
--0
--0
--0
-95.79%1.06M
192.14%50.41M
83.44%-2.68M
126.92%10.37M
--17.66M
--25.06M
Net other investing changes
200.00%3M
----
----
----
----
---3M
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-92.43%2.06M
122.73%1.98M
-118.77%-1.37M
-89.35%1.66M
-101.65%-214K
130.24%27.16M
56.60%-8.69M
111.99%7.29M
334.81%15.61M
650.95%12.96M
Financing cash flow
Cash flow from continuing financing activities
180.14%4.67M
-1.10%-734K
-115.27%-1.31M
1,917.18%7.61M
78.02%-896K
-104.67%-5.83M
78.52%-726K
-111.30%-609K
-100.34%-419K
-883.36%-4.08M
Net issuance payments of debt
-35.10%-3.01M
-7.99%-784K
-23.32%-751K
-76.37%-739K
-55.14%-740K
-101.48%-2.23M
-21.11%-726K
-100.40%-609K
-21.07%-419K
-15.05%-477K
Net common stock issuance
192.33%9.34M
--0
--0
--9.17M
--168K
--3.19M
--3.19M
--0
--0
--0
Net other financing activities
75.71%-1.65M
101.57%50K
---560K
---816K
91.00%-324K
14.29%-6.79M
-22.23%-3.19M
--0
--0
---3.6M
Cash from discontinued financing activities
Financing cash flow
180.14%4.67M
-1.10%-734K
-115.27%-1.31M
1,917.18%7.61M
78.02%-896K
-104.67%-5.83M
78.52%-726K
-111.30%-609K
-100.34%-419K
-883.36%-4.08M
Net cash flow
Beginning cash position
-13.01%36.94M
71.98%33.33M
908.99%8.53M
9.37%16.07M
-13.01%36.94M
145.99%42.46M
-65.15%19.38M
-99.28%845K
305.35%14.69M
145.99%42.46M
Current changes in cash
393.45%16.08M
98.19%10.43M
7.58%20.05M
503.74%6.48M
24.84%-20.87M
-121.75%-5.48M
120.74%5.26M
134.94%18.63M
-101.41%-1.61M
-172.69%-27.77M
Effect of exchange rate changes
247.62%62K
3,000.00%62K
--0
----
----
---42K
457.10%2K
-46,775.00%-45K
----
----
End cash Position
71.35%39.34M
71.35%39.34M
71.98%33.33M
908.99%8.53M
9.37%16.07M
-23.89%22.96M
-23.89%22.96M
-65.15%19.38M
-99.28%845K
305.35%14.69M
Free cash flow
108.60%4.12M
-31.27%8.02M
140.69%21.36M
78.36%-4.23M
56.97%-21.03M
-5.66%-47.87M
301.47%11.67M
143.92%8.87M
-111.15%-19.55M
-385.98%-48.87M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 134.90%9.36M-37.42%9.19M90.10%22.72M83.35%-2.8M46.08%-19.76M-170.30%-26.81M849.41%14.68M477.35%11.95M-542.93%-16.79M-394.15%-36.65M
Net income from continuing operations 79.88%-15.57M58.75%-12.85M56.37%27.35M47.53%-9.98M55.05%-20.09M-83.64%-77.36M-82.76%-31.14M409.48%17.49M-316.89%-19.02M-200.44%-44.69M
Operating gains losses -28,127.78%-5.05M76.78%-398K-175.43%-1.85M-231.56%-1.88M57.66%-912K-99.51%18K-233.59%-1.71M54.10%2.45M--1.43M-375.63%-2.15M
Depreciation and amortization 57.37%17.45M214.85%2.69M118.58%11.47M-38.24%2M-26.33%1.29M21.98%11.09M61.60%855K17.48%5.25M14.39%3.24M38.21%1.75M
Deferred tax -233.92%-1.14M-90.64%-652K--0-----------342K---342K--0--------
Other non cash items -51.54%550K-251.83%-621K115.70%522K80.41%442K-13.39%207K-72.90%1.14M30.85%409K21.53%242K-68.33%245K-91.77%239K
Change In working capital 73.86%-3.05M-47.78%18.57M9.71%-18.13M127.08%2.64M64.75%-6.13M-202.93%-11.68M174.60%35.57M-1,227.48%-20.08M-275.59%-9.76M-795.53%-17.4M
-Change in receivables -96.59%-2.13M-24.57%18.32M-7.17%-14.56M55.63%-5.08M-140.53%-813K-18,183.33%-1.09M122.99%24.29M-116.54%-13.59M-146.38%-11.45M-1,065.94%-338K
-Change in inventory -108.17%-104K----------------595.63%1.27M----------------
-Change in prepaid assets 196.01%2.29M-41.38%983K108.07%58K191.04%1.62M90.27%-379K-540.05%-2.38M2,606.58%1.68M13.15%-719K1,756.92%558K-800.37%-3.9M
-Change in payables and accrued expense 67.30%-3.1M-107.01%-673K37.57%-3.57M438.31%6.1M65.82%-4.95M-182.27%-9.48M351.33%9.6M-202.67%-5.73M-44.75%1.13M-917.97%-14.49M
-Change in other current assets ---------7.55%-57K---1K-99.10%12K-----------53K--0856.03%1.33M
Cash from discontinued investing activities
Operating cash flow 134.90%9.36M-37.42%9.19M90.10%22.72M83.35%-2.8M46.08%-19.76M-170.30%-26.81M849.41%14.68M477.35%11.95M-542.93%-16.79M-394.15%-36.65M
Investing cash flow
Cash flow from continuing investing activities -92.43%2.06M122.73%1.98M-118.77%-1.37M-89.35%1.66M-101.65%-214K130.24%27.16M56.60%-8.69M111.99%7.29M334.81%15.61M650.95%12.96M
Capital expenditure reported -252.44%-1.16M44.21%-183K---217K---444K---312K---328K---328K--0--0--0
Net PPE purchase and sale 82.76%-3.44M68.67%-841K62.61%-1.15M76.36%-486K92.09%-957K43.25%-19.92M30.00%-2.68M86.18%-3.08M69.06%-2.06M-414.56%-12.1M
Net business purchase and sale --2.59M--0--0----------0--0--0--------
Net investment purchase and sale -97.91%1.06M--0--0--0-95.79%1.06M192.14%50.41M83.44%-2.68M126.92%10.37M--17.66M--25.06M
Net other investing changes 200.00%3M-------------------3M----------------
Cash from discontinued investing activities
Investing cash flow -92.43%2.06M122.73%1.98M-118.77%-1.37M-89.35%1.66M-101.65%-214K130.24%27.16M56.60%-8.69M111.99%7.29M334.81%15.61M650.95%12.96M
Financing cash flow
Cash flow from continuing financing activities 180.14%4.67M-1.10%-734K-115.27%-1.31M1,917.18%7.61M78.02%-896K-104.67%-5.83M78.52%-726K-111.30%-609K-100.34%-419K-883.36%-4.08M
Net issuance payments of debt -35.10%-3.01M-7.99%-784K-23.32%-751K-76.37%-739K-55.14%-740K-101.48%-2.23M-21.11%-726K-100.40%-609K-21.07%-419K-15.05%-477K
Net common stock issuance 192.33%9.34M--0--0--9.17M--168K--3.19M--3.19M--0--0--0
Net other financing activities 75.71%-1.65M101.57%50K---560K---816K91.00%-324K14.29%-6.79M-22.23%-3.19M--0--0---3.6M
Cash from discontinued financing activities
Financing cash flow 180.14%4.67M-1.10%-734K-115.27%-1.31M1,917.18%7.61M78.02%-896K-104.67%-5.83M78.52%-726K-111.30%-609K-100.34%-419K-883.36%-4.08M
Net cash flow
Beginning cash position -13.01%36.94M71.98%33.33M908.99%8.53M9.37%16.07M-13.01%36.94M145.99%42.46M-65.15%19.38M-99.28%845K305.35%14.69M145.99%42.46M
Current changes in cash 393.45%16.08M98.19%10.43M7.58%20.05M503.74%6.48M24.84%-20.87M-121.75%-5.48M120.74%5.26M134.94%18.63M-101.41%-1.61M-172.69%-27.77M
Effect of exchange rate changes 247.62%62K3,000.00%62K--0-----------42K457.10%2K-46,775.00%-45K--------
End cash Position 71.35%39.34M71.35%39.34M71.98%33.33M908.99%8.53M9.37%16.07M-23.89%22.96M-23.89%22.96M-65.15%19.38M-99.28%845K305.35%14.69M
Free cash flow 108.60%4.12M-31.27%8.02M140.69%21.36M78.36%-4.23M56.97%-21.03M-5.66%-47.87M301.47%11.67M143.92%8.87M-111.15%-19.55M-385.98%-48.87M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
+14.85%
New Fortress Energy
NFE
+7.92%
Cars.com
CARS
+2.11%
Halozyme Therapeutics
HALO
+1.31%
Collegium Pharmaceutical
COLL
+0.40%

Unlock the Full List